Want to see RCKT full AI Analyst Report?
Rocket Pharmaceuticals (RCKT) Ownership Overview
20.46% Insiders
14.92% Mutual Funds
32.36% Other Institutional Investors
11.77% ETFs
20.50% Public Companies and
Individual Investors
The ownership structure of Rocket Pharmaceuticals (RCKT) stock is a mix of institutional, retail, and individual investors. Approximately 59.04% of the company’s stock is owned by Institutional Investors, 20.46% is owned by Insiders, and 20.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 15, 2026 | xxxxxxxxxxxxx | $256238 | |
Aug 20, 2026 | xxxxxxxxxxxxx | $2133 | |
Aug 20, 2026 | xxxxxxxxxxxxx | $7750 | |
Aug 17, 2026 | xxxxxxxxxxxxx | $9589 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $13419953 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,263,956 | Insider | 16.64% | 47,394,966 | |
| 4,621,263 | Institution | 4.21% | 11,992,177 | |
| 4,591,845 | Institution | 4.18% | 11,915,838 | |
| 3,923,963 | Institution | 3.57% | 10,182,684 | |
| 3,691,777 | Institution | 3.36% | 9,580,161 | |
| 2,175,194 | Institution | 1.98% | 5,644,628 | |
| 2,012,558 | Institution | 1.83% | 5,222,588 | |
| 1,462,832 | Insider | 1.33% | 3,796,049 | |
| 1,422,630 | Institution | 1.30% | 3,691,725 | |
| 981,672 | Institution | 0.89% | 2,547,439 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,691,777 | Institution | 3.36% | 9,580,161 | |
| 2,175,194 | Institution | 1.98% | 5,644,628 | |
| 2,012,558 | Institution | 1.83% | 5,222,588 | |
| 1,422,630 | Institution | 1.30% | 3,691,725 | |
| 981,672 | Institution | 0.89% | 2,547,439 | |
| 950,469 | Institution | 0.87% | 2,466,467 | |
| 946,774 | Institution | 0.86% | 2,456,879 | |
| 488,238 | Institution | 0.44% | 1,266,978 | |
| 476,057 | Institution | 0.43% | 1,235,368 | |
| 464,628 | Institution | 0.42% | 1,205,710 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,700,288 | Institution | 2.46% | 10,045,071 | |
| 2,352,370 | Institution | 2.14% | 6,104,400 | |
| 1,046,936 | Institution | 0.95% | 3,894,602 | |
| 957,018 | Institution | 0.87% | 2,483,462 | |
| 845,570 | Institution | 0.77% | 2,194,254 | |
| 803,433 | Institution | 0.73% | 2,084,909 | |
| 518,479 | Institution | 0.47% | 1,928,742 | |
| 452,499 | Institution | 0.41% | 1,217,222 | |
| 293,156 | Institution | 0.27% | 760,740 | |
| 292,542 | Institution | 0.27% | 759,146 |
FAQ
Who Owns Rocket Pharmaceuticals (RCKT)?
According to the latest TipRanks data, approximately 32.36% of the company's stock is held by institutional investors, 20.46% is held by insiders, and 20.50% is held by retail investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.36% of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.50% of Rocket Pharmaceuticals (RCKT) stock is held by retail investors.
Who owns the most shares of Rocket Pharmaceuticals (RCKT)?
RODERICK WONG owns the most shares of Rocket Pharmaceuticals (RCKT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.